Tag: Epstein-Barr virus

A pre-relapse immune signature implicates EBV reactivation in MS relapse

Presented By
Dr Devin King, Brigham and Women’s Hospital, MA, USA
Conference
ACTRIMS 2025
Type
News article

28 March 2025 11:03

Ineffective response to EBV in MS not seen in similar diseases

Presented By
Dr Tilman Schneider-Hohendorf, University of Münster, Germany
Conference
ECTRIMS 2024
Type
Peer-reviewed article

18 November 2024 12:01

New insights into the contribution of EBV to MS pathogenesis

Presented By
Prof. Thomas Berger, Medical University of Vienna, Austria
Conference
MSMilan 2023
Type
Peer-reviewed article

4 December 2023 11:10

MS associated with a broader Epstein-Barr virus specific T-cell receptor repertoire

Presented By
Dr Tilman Schneider-Hohendorf, University of Muenster, Germany
Conference
ECTRIMS 2022
Type
Peer-reviewed article

20 December 2022 11:58

ECTRIMS 2022 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
ECTRIMS 2022

15 November 2022 00:08

Epstein-Barr virus-targeted T-cell immunotherapy for progressive MS

Principal Investigator
Prof. Amit Bar-Or, University of Pennsylvania, PA, USA
Conference
EAN 2020
Type
Peer-reviewed article

10 September 2020 12:30

Generalised EBV vaccine for progressive MS well-tolerated

Conference
EAN 2019
Type
Peer-reviewed article

27 August 2019 15:37
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com